CAPITAL IMPACT ADVISORS, LLC United Therapeutics Corporation Transaction History

CAPITAL IMPACT ADVISORS, LLC portfolio value:

$209,000
portfolio value

CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:

-11.14%
quarter

United Therapeutics Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -19.65% -244 shares -84K $209.38 998
Q2 2022 share Decrease -45.93% -1.05K shares -119K $235.64 1.24K
Q1 2022 share Decrease -69.26% -5.17K shares -1.20M $179.41 2.29K
Q4 2021 share Decrease -50.00% -7.47K shares -1.14M $215.18 7.47K
Q3 2021 share Decrease -15.26% -2.69K shares -405K $184.58 14.94K
Q2 2021 share 0.00% 0 shares 214K $179.41 17.63K
Q1 2021 share Decrease -7.32% -1.39K shares 61K $167.27 17.63K
Q4 2020 share Decrease -13.72% -3.02K shares 661K $151.79 19.03K
Q3 2020 share 0.00% 0 shares -441K $101 22.05K
Q2 2020 share Decrease -59.89% -32.93K shares -2.54M $121 22.05K
Q1 2020 share Increase +6.15% 3.18K shares 652K $94.83 54.99K
Q4 2019 share 0.00% 0 shares 375K $88.08 51.81K
Q3 2019 share Increase +78.07% 22.71K shares 1.94M $79.75 51.81K
Q2 2019 share Increase +34.07% 7.39K shares -39K $78.06 29.09K
Q1 2019 share 0.00% 0 shares 0 $117.37 21.70K
Q4 2018 share Decrease -7.75% -1.82K shares -693K $108.9 21.70K
Q3 2018 share 0.00% 0 shares 350K $127.88 23.52K
Q2 2018 share Increase +22.49% 4.31K shares 465K $113.15 23.52K
Q1 2018 share Increase +19.29% 3.10K shares -224K $112.36 19.20K
Q4 2017 share 0.00% 0 shares 495K $147.95 16.1K
Q3 2017 share Increase +6.59% 996 shares -72K $117.19 16.1K
Q2 2017 share Decrease -10.90% -1.84K shares -336K $129.73 15.10K
Q1 2017 share Decrease -52.91% -19.04K shares -2.86M $135.38 16.95K
Q4 2016 share 0.00% 0 shares 913K $143.43 35.99K
Q3 2016 share Increase +19.60% 5.9K shares 1.06M $118.08 35.99K
Q2 2016 share Increase +391.03% 23.96K shares 2.50M $105.92 30.09K
Q1 2016 share Increase +173.74% 3.89K shares 332K $111.43 6.12K